Status:
RECRUITING
Evaluation of Urinary Exosomes Presence From Clear Cell Renal Cell Carcinoma
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Conditions:
Clear Cell Renal Cell Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
Clear cell renal cell carcinoma is diagnosed by imaging, sometimes associated with biopsy. This diagnosis is expensive, invasive and sometimes late. The development of a simple biological test for dia...
Detailed Description
The primary objective is to detect urinary exosomes, by electron microscopy technique, from clear cell renal cell carcinoma due to exosome markers (CD9) and clear cell kidney cancer (CA9).
Eligibility Criteria
Inclusion
- Patients:
- All patients with renal mass requiring surgery (partial or total nephrectomy)
- Social security affiliation
- Signed informed consent
- Control :
- Unscheduled nephrectomy
- Social security affiliation
- Signed informed consent
Exclusion
- Insufficient volume of urine sample (\< 100 ml)
- Patients with a urinary catheter
- Patients under court-ordered guardianship or curators
Key Trial Info
Start Date :
January 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04053855
Start Date
January 29 2020
End Date
August 1 2026
Last Update
October 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Saint-Etienne
Saint-Etienne, France